Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Carcinosarcoma of the corpus uteri as an associated condition reference and included a link to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new site revision v3.4.3 was added and the previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a new revision label (v3.4.2) replacing the previous (v3.4.1). This appears to be a cosmetic version update.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0; no substantive content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedThe label 'Last Update Posted (Estimated)' in the Study Record Dates section has been replaced with 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.